BRIEF published on 01/23/2026 at 08:05, 4 months ago Transgene renforce son conseil scientifique consultatif avec de nouvelles nominations Transgene Immunothérapie Du Cancer Ignacio Melero Conseil Scientifique Consultatif Antoine L'Italien
BRIEF published on 01/23/2026 at 07:05, 4 months ago Reinet Investments S.C.A. Reports Third Quarter Results for 2025 Shareholder Information Investment Fund Quarterly Results Luxembourg Stock Exchange Reinet Investments
BRIEF published on 01/23/2026 at 07:05, 4 months ago Reinet Investments SCA publie ses résultats du troisième trimestre 2025 Fonds D'investissement Résultats Trimestriels Bourse De Luxembourg Investissements Reinet Informations Destinées Aux Actionnaires
BRIEF published on 01/23/2026 at 07:05, 4 months ago Mikron Announces CHF 381.9 Million Net Sales for 2025 Net Sales Financial Outlook Machining Solutions Mikron Automation Growth
BRIEF published on 01/23/2026 at 07:05, 4 months ago Mikron annonce un chiffre d'affaires net de 381,9 millions de francs suisses pour 2025 Perspectives Financières Ventes Nettes Solutions D'usinage Mikron Croissance De L'automatisation
BRIEF published on 01/23/2026 at 07:05, 4 months ago BB Biotech AG Reports Significant Profit for 2025 Investment Company BB Biotech AG Drug Developers 2025 Profit Share Price Development
BRIEF published on 01/23/2026 at 07:05, 4 months ago BB Biotech AG annonce des bénéfices importants pour 2025 BB Biotech AG Société D'investissement Développeurs De Médicaments Bénéfices 2025 Évolution Du Cours De L'action
BRIEF published on 01/23/2026 at 07:05, 4 months ago BB Biotech Reports Strong Preliminary 2025 Results and Dividend Proposal Dividend Proposal Share Performance BB Biotech Biotech Investment 2025 Financial Results
BRIEF published on 01/23/2026 at 07:05, 4 months ago BB Biotech annonce des résultats préliminaires solides pour 2025 et une proposition de dividende Proposition De Dividende BB Biotech Performance Des Actions Résultats Financiers 2025 Investissement En Biotechnologie
BRIEF published on 01/23/2026 at 07:05, 4 months ago Vallourec dévoile Delphy à Hyvolution 2026 Innovation Transition Énergétique Stockage Hydrogène Vallourec
Published on 05/23/2026 at 03:15, 10 hours 55 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 11 hours 10 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 11 hours 45 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 11 hours 45 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 13 hours 10 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 16 hours 5 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 16 hours 5 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 18 hours 19 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 19 hours 37 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 19 hours 40 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 18 hours 35 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 20 hours 5 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 20 hours 5 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 1 hour ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 1 hour ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
